Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 15, 2017
Role of Glutamatergic Projections from the Ventral CA1 to Infralimbic Cortex in Context-Induced Reinstatement of Heroin SeekingNa Wang, Feifei Ge, Cailian Cui, et al.Structure (London, England : 1993)|April 6, 2024
Cryo-EM structures reveal two allosteric inhibition modes of PI3KαH1047R involving a re-shaping of the activation loopXiuliang Huang, Kailiang Wang, Jing Han, et al.Artificial Cells, Nanomedicine, and Biotechnology|March 8, 2018
RIP140/PGC-1α axis involved in vitamin A-induced neural differentiation by increasing mitochondrial functionQing Mu, Weidong Yu, Shuying Zheng, et al.Molecular Cancer Therapeutics|August 1, 2024
Discovery of RGT-018: A Potent, Selective, and Orally Bioavailable SOS1 Inhibitor for KRAS-Driven CancersFei Xiao, Kailiang Wang, Xinjuan Wang, et al.ACS Medicinal Chemistry Letters|March 16, 2023
Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug DesignYang Yu, Junhong Huang, Hu He, et al.Drug Delivery and Translational Research|August 24, 2018
The synthesized transporter K16APoE enabled the therapeutic HAYED peptide to cross the blood-brain barrier and remove excess iron and radicals in the brain, thus easing Alzheimer's diseaseZhenyou Zou, Qiqiong Shen, Yanxia Pang, et al.Alzheimer'S & Dementia (New York, N. Y.)|January 11, 2020
Linking the low-density lipoprotein receptor-binding segment enables the therapeutic 5-YHEDA peptide to cross the blood-brain barrier and scavenge excess iron and radicals in the brain of senescent miceZhenyou Zou, Shengxi Shao, Ruyi Zou, et al.Pageof 5